Evelyn Peelen

Evelyn Peelen

Company: Immunic Therapeutics

Job title: Senior Manager Translational Pharmacology

Seminars:

IMU-935, a potent RORyt inverse agonist, effectively inhibits T helper 17 cells but maintains normal thymocyte development 11:00 am

Learn how IMU-935 is a potent RORyt inverse agonist Explore how IMU-935 does not induce thymocyte aberrations and thereby allows a normal thymocyte maturation Discuss how IMU-935 is in phase 1 clinical development for psoriasisRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.